Related Experiment Video
Updated: May 5, 2026
06:08
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
Published on: January 7, 2019
8.6K
Melancholia: definition and management.
Gordon Parker1, Amelia Paterson
1School of Psychiatry, University of New South Wales and Black Dog Institute, Sydney, New South Wales, Australia.
Current Opinion in Psychiatry
|November 26, 2013
Summary
Diagnosing melancholic depression requires more than symptoms alone. A prototypic approach combined with biological markers like the Hypothalamic-Pituitary-Adrenal axis may improve accuracy.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Melancholia, a severe subtype of depression, has a complex diagnostic history.
- Current diagnostic criteria may limit precise differentiation and research into its causes and treatments.
Purpose of the Study:
- To review the historical context and current nosological status of melancholia.
- To examine diagnostic strategies, biological markers, and treatment studies related to melancholic depression.
Main Methods:
- Literature review of historical and current research on melancholia.
- Analysis of diagnostic approaches, including symptom-based and prototypic strategies.
- Evaluation of biological markers and recent clinical trial data for treatment implications.
Main Results:
- Symptom-based diagnosis is insufficient; prototypic approaches integrating illness correlates enhance precision.
- Hyperactive Hypothalamic-Pituitary-Adrenal axis functioning is a supported biological marker, while others need further validation.
- Recent clinical trials offer insights into treatment implications for melancholic depression.
Conclusions:
- The current Diagnostic and Statistical Manual (DSM-5) definition of melancholia may hinder research due to limited differentiating capacity.
- More precise definition of melancholia is crucial for understanding its etiology and optimizing differential treatment responsiveness.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
747
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.8K
Related Concept Videos
01:27Depressive Disorders: MDD and Dysthymia
1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:24Mania and Antimanic Drugs: Overview
808
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
808
01:19Management of Insomnia
788
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
788
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:27Depressive Disorders: Etiology
887
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
887